Record Display for the EPA National Library Catalog

RECORD NUMBER: 92 OF 1237

OLS Field Name OLS Field Data
Main Title Carcinogenic Activity Associated with Halogenated Acetones and Acroleins in the Mouse Skin Assay.
Author Robinson, M. ; Bull, R. J. ; Olson, G. R. ; Stober, J. ;
CORP Author Health Effects Research Lab., Research Triangle Park, NC. ;Pathology Associates, Inc., West Chester, OH. ;Washington State Univ., Pullman. Coll. of Pharmacy.
Publisher c1989
Year Published 1989
Report Number EPA/600/J-89/324;
Stock Number PB90-216029
Additional Subjects Skin ; Acroleins ; Toxicology ; Chlorinated hydrocarbons ; Acetone ; Brominated hydrocarbons ; Tables(Data) ; Mice ; Salmonella typhimurium ; Reprints ; Carcinogenicity tests ; Mutagenicity tests ; Papilloma
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
NTIS  PB90-216029 Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy. NTIS 08/27/1990
Collation 10p
Abstract
Several chlorinated acetones have been identified in drinking water and these as well as a number of chlorinated acroleins are produced by chlorination of humic acid solutions. Many of these chlorinated compounds and the brominated acrolein analog were positive in the Ames assay in the laboratory. To determine if carcinogenic activity was associated with these chemicals halogenated acetone derivatives were applied topically to SENCAR mice at the various dose levels. Doses were applied six times over a two-week period in 0.2 ml ethanol per application. Control animals received 0.2 ml ethanol per application as single dose or multiple doses to match corresponding study. Two weeks after final dose, 1.0 micro g TPA in 0.2 ml acetone was applied three times weekly for 20 weeks. After 24 weeks the percent of animals with tumor for dose groups above were reported. The data show that 1,3-DCA, CAC, and BAC, when applied topically, initiate tumors in the mouse skin. These chemicals administered orally in a 2% emulphor solution, at doses described in table 3, did not initiate tumors in the mouse skin.